FCGR3A and colorectal carcinoma: Indeed, the immune cell populations recruited in CRC significantly differ from those tested in these in vitro experiments, as we detected only scarce NK cells in line with other previous studies, but numerous FcγRIIIA+ (CD16) TAN which are known not to express (or scarcely) the inhibitory CD94/NKG2A receptor (31).